Predicted to enable methylenetetrahydrofolate reductase (NAD(P)H) activity. Predicted to be involved in methionine metabolic process. Is an ortholog of C. elegans mthf-1.
Predicted to enable oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor. Predicted to be involved in heme A biosynthetic process. Predicted to be located in membrane. Is an ortholog of C. elegans C33A11.2.
Predicted to enable metallopeptidase activity and translation initiation factor activity. Predicted to be located in cytoplasm. Predicted to be part of eukaryotic translation initiation factor 3 complex. Is an ortholog of C. elegans eif-3.H.
Predicted to enable oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor. Predicted to be involved in heme A biosynthetic process. Predicted to be located in membrane. Is an ortholog of C. elegans cox-15.
Predicted to enable RNA binding activity. Predicted to be involved in box H/ACA snoRNP assembly; pseudouridine synthesis; and ribosome biogenesis. Predicted to be part of sno(s)RNA-containing ribonucleoprotein complex. Is an ortholog of C. elegans F25H8.2.
Enriched in body wall based on proteomic studies. Is predicted to encode a protein with the following domains: NAD(P)-binding domain superfamily; NAD(P)H-binding; and NAD(P)-binding domain. Is an ortholog of C. elegans nduf-9.